Healius Ltd - Asset Resilience Ratio
Healius Ltd (HLS) has an Asset Resilience Ratio of 0.06% as of December 2015. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Healius Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2017)
This chart shows how Healius Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see HLS total asset value.
Liquid Assets Composition Over Time
This chart breaks down Healius Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Healius Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 0% |
| Short-term Investments | AU$2.43 Million | 0.06% |
| Total Liquid Assets | AU$2.43 Million | 0.06% |
Asset Resilience Insights
- Limited Liquidity: Healius Ltd maintains only 0.06% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Healius Ltd Industry Peers by Asset Resilience Ratio
Compare Healius Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
|
Scope Fluidics SA
WAR:SCP |
Diagnostics & Research | 16.51% |
|
Eurofins-Cerep SA
PA:ALECR |
Diagnostics & Research | 13.42% |
|
Check-Cap Ltd
F:7CC |
Diagnostics & Research | 2.90% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
Annual Asset Resilience Ratio for Healius Ltd (2002–2017)
The table below shows the annual Asset Resilience Ratio data for Healius Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2017-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$3.11 Billion ≈ $2.20 Billion |
-- |
| 2016-06-30 | 0.00% | AU$0.00 ≈ $0.00 |
AU$3.62 Billion ≈ $2.56 Billion |
-- |
| 2015-06-30 | 0.08% | AU$3.20 Million ≈ $2.26 Million |
AU$3.92 Billion ≈ $2.77 Billion |
-0.04pp |
| 2012-06-30 | 0.12% | AU$4.57 Million ≈ $3.24 Million |
AU$3.86 Billion ≈ $2.73 Billion |
+0.10pp |
| 2011-06-30 | 0.02% | AU$798.00K ≈ $564.64K |
AU$3.83 Billion ≈ $2.71 Billion |
-0.02pp |
| 2010-06-30 | 0.04% | AU$1.50 Million ≈ $1.06 Million |
AU$3.70 Billion ≈ $2.62 Billion |
-0.14pp |
| 2009-06-30 | 0.18% | AU$6.93 Million ≈ $4.91 Million |
AU$3.78 Billion ≈ $2.67 Billion |
+0.18pp |
| 2008-06-30 | 0.00% | AU$115.00K ≈ $81.37K |
AU$4.80 Billion ≈ $3.40 Billion |
-0.02pp |
| 2007-06-30 | 0.02% | AU$135.00K ≈ $95.52K |
AU$606.50 Million ≈ $429.14 Million |
+0.02pp |
| 2002-06-30 | 0.00% | AU$-6.00K ≈ $-4.25K |
AU$283.35 Million ≈ $200.49 Million |
-- |
About Healius Ltd
Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more